We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

55 hedge funds and large institutions have $47.5M invested in ProQR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

20% more funds holding

Funds holding: 46 → 55 (+9)

4.22% more ownership

Funds ownership: 23.4% → 27.62% (+4.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

21% less capital invested

Capital invested by funds: $60M → $47.5M (-$12.4M)

26% less call options, than puts

Call options by funds: $705K | Put options by funds: $950K

Holders
55
Holders Change
+9
Holders Change %
+19.57%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
18
Reduced
4
Closed
8
Calls
$705K
Puts
$950K
Net Calls
-$245K
Net Calls Change
-$154K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$8.87M
2
Millennium Management
Millennium Management
New York
+$3.43M
3
DCM
DAFNA Capital Management
California
+$2.88M
4
Morgan Stanley
Morgan Stanley
New York
+$826K
5
JP Morgan Chase
JP Morgan Chase
New York
+$675K

Top Sellers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
-$2.47M
2
AIC
AWM Investment Company
New York
-$617K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$504K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$381K
5
GGHC
Gilder Gagnon Howe & Co
New York
-$359K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFM
1
Privium Fund Management
Netherlands
$11.4M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$7.72M – – –
EC
3
EcoR1 Capital
California
$6.18M +$8.87M +2,902,715 New
MCM
4
M28 Capital Management
Connecticut
$4.07M – – –
Millennium Management
5
Millennium Management
New York
$2.79M +$3.43M +1,121,490 +594%
DCM
6
DAFNA Capital Management
California
$2M +$2.88M +940,582 New
OM
7
Opaleye Management
Massachusetts
$1.39M -$2.47M -807,000 -55%
Morgan Stanley
8
Morgan Stanley
New York
$1.38M +$826K +270,208 +71%
Marshall Wace
9
Marshall Wace
United Kingdom
$1.34M +$631K +206,311 +49%
Macquarie Group
10
Macquarie Group
Australia
$1.32M – – –
IC
11
Ikarian Capital
Texas
$1.01M +$153K +50,000 +12%
Two Sigma Investments
12
Two Sigma Investments
New York
$890K +$335K +109,463 +35%
Deutsche Bank
13
Deutsche Bank
Germany
$820K – – –
Two Sigma Advisers
14
Two Sigma Advisers
New York
$797K +$375K +122,500 +49%
JP Morgan Chase
15
JP Morgan Chase
New York
$474K +$675K +220,778 +12,279%
UOC
16
UBS O'Connor
Illinois
$383K +$550K +180,000 New
MAM
17
Monaco Asset Management
Monaco
$382K +$43.8K +14,334 +9%
HF
18
HRT Financial
New York
$364K +$524K +171,306 New
Bank of America
19
Bank of America
North Carolina
$326K +$369K +120,566 +373%
FSA
20
Franklin Street Advisors
North Carolina
$320K – – –
CSS
21
Cubist Systematic Strategies
Connecticut
$215K +$48.2K +15,756 +18%
Citadel Advisors
22
Citadel Advisors
Florida
$213K +$305K +99,779 New
BFM
23
Boothbay Fund Management
New York
$204K +$16.7K +5,460 +6%
VF
24
Virtu Financial
New York
$201K +$289K +94,564 New
OQS
25
Occudo Quantitative Strategies
Florida
$189K +$271K +88,617 New
1
2 3

PRQR Hedge Fund Activity: Q1 2023 in Review

55 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2023, worth a combined $47.5M — down 21% from $60M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PRQR positions and 8 closed out — a net gain of 9 holders — while 18 added to existing stakes and 4 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $8.87M. The largest seller was Opaleye Management, cutting an estimated $2.47M.

  • 55 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2023, up from 46 in Q4 2022.
  • Funds reported $47.5M of ProQR Therapeutics stock for Q1 2023, down 21% quarter-over-quarter.
  • 17 funds opened new ProQR Therapeutics positions in Q1 2023 and 8 closed out, a net change of +9 holders.
  • The largest ProQR Therapeutics buyer in Q1 2023 was EcoR1 Capital, an estimated $8.87M added.
  • The largest ProQR Therapeutics seller in Q1 2023 was Opaleye Management, an estimated $2.47M sold.

Based on aggregated 13F filings for Q1 2023.